arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Teleflex Incorporated

TFX Health Care Medical/Dental Instruments
$136.58
▲ +4.1% Today
as of Oct 22, 16:52 ET
Last 30 days +4.82% Sep 14 → Oct 22
$118.77 $123.55 $128.33 $133.12 $137.90 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$132.30
High
$137.01
Low
$131.49
Volume
$697,968
Avg Vol
$758,066
Mkt Cap
$5.3B
P/E (TTM)
62.11
Beta
—
52w High
$145.00
52w Low
$100.18
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

Oct 22 · 12:52 MT Newswires
Teleflex Wins FDA Breakthrough Designation for Resorbable Heart Scaffold
Oct 22 · 10:45 PR Business Wire
Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold
Oct 22 · 10:30 PR Business Wire
Teleflex Announces Third Quarter 2026 Earnings Conference Call Information
▸ Show all 25 press releases & news Free account →

TFX earnings at a glance

Teleflex Incorporated (TFX) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Analysts expect earnings per share of $1.92, compared with $3.67 in the same quarter last year (-48%). The options market is pricing a move of about ±4.6% after the report, a range of roughly $130.31 to $142.85 from today's $136.58. Over its last 6 reports the stock rose the next day 4 times and fell 2, moving ±6.8% on average; after the most recent report on Aug 6, 2026 it moved +1.5%. That means options currently expect less movement than TFX has typically delivered. TFX beat the consensus EPS estimate in 5 of its last 6 reported quarters. Implied volatility is currently 39%. The share price of $136.58 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$100
$145
81% of range
Avg surprise (last 6)
+4.1%
Avg reaction (last 6)
-0.2%
67% positive
Latest IV / EM
39%
EM ±4.6% · $125 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.21$1.84$2.47$3.10$3.73 Actual $1.62Actual $2.35Actual $2.90Actual $2.91Est $2.88Actual $3.73Est $3.36Actual $3.67Est $3.38Actual $1.93Est $3.73Actual $1.39Est $1.21Actual $1.76Est $1.28 AprJulOctMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-8M$144M$295M$447M$599M Mar 25Jun 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Aug 6, 2026Jun/2026 $1.76 $1.28 +37.5% -65.7% +1.5% earnings
Thu May 7, 2026Mar/2026 $1.39 $1.21 +14.9% -52.2% +6.9% earnings
Thu Feb 26, 20268K 2026-02-26 $1.93 $3.73 -48.3% — +6.4% earnings
Thu Nov 6, 2025Sep/2025 $3.67 $3.38 +8.6% — -13.0% earnings
Thu Jul 31, 2025Jun/2025 $3.73 $3.36 +11.0% — +4.9% earnings
Thu May 1, 2025Mar/2025 $2.91 $2.88 +1.0% — -8.2% earnings
Sun Oct 1, 2023Oct 2023 $2.90 — — — — financials
Sun Jul 2, 2023Jul 2023 $2.35 — — — — financials
Sun Apr 2, 2023Apr 2023 $1.62 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Nov 5, 2026Sep/2026OTHER $1.92$3.67 -47.7%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$570M$548M——$443M$414M——
Cost of revenue$239M$241M—$461M$177M$159M—$334M
Gross profit$332M$307M——$266M$255M——
Operating income$73M$20M——$91M$76M——
Net income$100M$-8M——$123M$95M——
EPS (diluted)$2.28$-0.18——$2.77$2.07——

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$300M$309M$379M$354M$254M$284M$290M$243M
Inventory$352M$381M$404M$802M$694M$644M$600M$640M
Total current assets$1.88B$1.86B$1.94B$1.99B$1.72B$1.54B$1.47B$1.50B
Total assets$6.79B$6.78B$6.95B$7.87B$7.38B$7.16B$7.10B$7.49B
Long-term debt$2.72B$2.51B$2.54B$2.57B$1.80B$1.81B$1.56B$1.66B
Total liabilities$3.88B$3.70B$3.82B$4.05B$3.13B$3.07B$2.82B$3.00B
Total equity$2.90B$3.08B$3.12B$3.82B$4.24B$4.10B$4.28B$4.48B

Implied volatility — last 90 days

30%69%108%148%187% Jun 07 — IV 54% · EM ±7.5%Jun 08 — IV 54% · EM ±7.1%Jun 09 — IV 57% · EM ±7.2%Jun 10 — IV 59% · EM ±6.9%Jun 11 — IV 62% · EM ±6.8%Jun 12 — IV 66% · EM ±6.7%Jun 15 — IV 92% · EM ±6.6%Jun 16 — IV 137% · EM ±8.1%Jun 17 — IV 187% · EM ±7.8%Jun 19 — IV 45% · EM ±9.9%Jun 22 — IV 47% · EM ±9.8%Jun 23 — IV 40% · EM ±8.2%Jun 24 — IV 38% · EM ±7.7%Jun 25 — IV 40% · EM ±7.8%Jun 26 — IV 38% · EM ±7.4%Jun 29 — IV 43% · EM ±7.6%Jun 30 — IV 47% · EM ±8.1%Jul 01 — IV 44% · EM ±7.4%Jul 02 — IV 41% · EM ±6.6%Jul 03 — IV 42% · EM ±6.6%Jul 06 — IV 54% · EM ±7.5%Jul 07 — IV 44% · EM ±5.8%Jul 08 — IV 52% · EM ±6.5%Jul 09 — IV 46% · EM ±5.5%Jul 10 — IV 48% · EM ±5.3%Jul 13 — IV 54% · EM ±4.5%Jul 14 — IV 71% · EM ±5.1%Jul 15 — IV 97% · EM ±5.7%Jul 16 — IV 65% · EM ±2.7%Jul 20 — IV 45% · EM ±10.5%Jul 21 — IV 45% · EM ±10.5%Jul 22 — IV 45% · EM ±10.4%Jul 23 — IV 48% · EM ±10.9%Jul 24 — IV 50% · EM ±11.0%Jul 27 — IV 49% · EM ±10.3%Jul 28 — IV 49% · EM ±10.1%Jul 29 — IV 49% · EM ±9.9%Jul 30 — IV 54% · EM ±10.5%Jul 31 — IV 59% · EM ±11.2%Aug 03 — IV 63% · EM ±11.1%Aug 04 — IV 61% · EM ±10.6%Aug 05 — IV 64% · EM ±10.6%Aug 06 — IV 56% · EM ±9.0%Aug 07 — IV 51% · EM ±8.0%Aug 10 — IV 65% · EM ±9.0%Aug 11 — IV 62% · EM ±8.2%Aug 12 — IV 71% · EM ±8.8%Aug 13 — IV 50% · EM ±5.9%Aug 14 — IV 46% · EM ±5.1%Aug 17 — IV 63% · EM ±5.3%Aug 18 — IV 61% · EM ±4.4%Aug 19 — IV 71% · EM ±4.2%Aug 20 — IV 51% · EM ±2.1%Aug 24 — IV 36% · EM ±7.5%Aug 25 — IV 37% · EM ±7.5%Aug 26 — IV 35% · EM ±6.9%Aug 27 — IV 35% · EM ±6.9%Aug 28 — IV 34% · EM ±6.6%Aug 31 — IV 33% · EM ±5.8%Sep 01 — IV 35% · EM ±6.0%Sep 02 — IV 36% · EM ±6.1%Sep 03 — IV 35% · EM ±5.7%Sep 04 — IV 35% · EM ±5.4%Sep 07 — IV 39% · EM ±5.4%Sep 08 — IV 39% · EM ±5.2%Sep 09 — IV 39% · EM ±4.9%Sep 10 — IV 45% · EM ±5.3%Sep 11 — IV 41% · EM ±4.6%Sep 14 — IV 59% · EM ±4.9%Sep 15 — IV 62% · EM ±4.5%Sep 16 — IV 71% · EM ±4.2%Sep 17 — IV 53% · EM ±2.2%Sep 21 — IV 36% · EM ±7.6%Sep 22 — IV 33% · EM ±6.8%Sep 23 — IV 36% · EM ±7.3%Sep 24 — IV 37% · EM ±7.2%Sep 25 — IV 37% · EM ±7.1%Sep 28 — IV 39% · EM ±6.9%Sep 29 — IV 37% · EM ±6.3%Sep 30 — IV 37% · EM ±6.2%Oct 01 — IV 35% · EM ±5.6%Oct 02 — IV 35% · EM ±5.4%Oct 06 — IV 31% · EM ±4.0%Oct 07 — IV 39% · EM ±4.9%Oct 08 — IV 39% · EM ±4.6%

Sector peers

STVN
Stevanato Group S.p.A.
$5.3B $19.50+2.6%
MMSI
Merit Medical Systems, Inc.
$5.1B $93.94+3.0%
MMED
MiniMed Group, Inc.
$5.7B $18.29+4.6%
HAE
Haemonetics Corporation
$4.6B $116.16-1.7%
HTFL
Heartflow, Inc.
$4.3B $55.43-0.3%
ICUI
ICU Medical, Inc.
$3.9B $168.33+4.5%

TFX earnings FAQ

When is TFX's next earnings date?

Teleflex Incorporated is expected to report on November 5, 2026.

What is TFX's expected move for earnings?

Options currently price a move of about ±4.6%, or $6.27 per share either way from $136.58.

How does TFX stock usually react to earnings?

Across the last 6 reports the average next-day move was ±6.8%, up 4 times and down 2 times.

What EPS are analysts expecting from Teleflex Incorporated?

The consensus estimate is $1.92 per share, versus $3.67 a year ago.

What is TFX's implied volatility?

TFX's at-the-money implied volatility is about 39% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in